文献速递心脏核医学

使用瑞加诺生的无创PET定量心肌血流量评估原位心脏移植患者的心脏移植血管病变

Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.
PubMed 文献 · J Nucl Cardiol · 2017-01-30

本研究纳入12例无移植后心肌缺血史的原位心脏移植患者(移植后5.4±2.0年)和15例作为对照的中度验前概率但无冠心病证据患者,采用动态13N-NH3 PET在静息和瑞加诺生诱导充血状态下评估整体和区域心肌血流量及冠状动脉血流储备。结果显示移植组静息心肌血流量较高,充血状态下中位心肌血流量较低,冠状动脉血流储备显著降低。研究提示移植患者静息心肌血流量可能异常且冠状动脉血流储备减低。

要点

  • 移植组静息心肌血流量高于对照组(1.33±0.31 vs 1.01±0.21 mL/min/g,P<.001)。
  • 移植组中位充血心肌血流量低于对照组(2.0 vs 2.60 mL/min/g,P=.018)。
  • 移植组冠状动脉血流储备较对照组显著降低(2.07±0.74 vs 2.63±0.48,P=.025)。

核心结论

  • 本研究提示原位心脏移植患者静息状态下心肌血流量可能异常,且冠状动脉血流储备减低。
  • 这暗示移植后心外膜和微血管冠状动脉子系统可能加重,导致心脏移植血管病变逐渐进展。

研究设计与样本

  • 研究纳入12例无移植后心肌缺血史的原位心脏移植患者(第1组,8男4女,平均年龄55±7岁),于移植后5.4±2.0年入组。
  • 另纳入15例中度验前概率但无冠心病证据的患者作为对照(第2组,9男6女,平均年龄71±9岁)。
  • 采用动态13N-NH3 PET在静息和瑞加诺生诱导充血状态下评估整体和区域心肌血流量,并计算充血与静息心肌血流量比值作为冠状动脉血流储备。

主要发现

  • 两组瑞加诺生诱导的速率-压力乘积均值相似,但第1组静息速率-压力乘积增高。
  • 第1组静息心肌血流量均数和中位数均高于第2组(1.33±0.31 vs 1.01±0.21 mL/min/g,P<.001)。
  • 两组充血心肌血流量均值相似(2.68±0.84 vs 2.64±0.94 mL/min/g,P=NS),但第1组中位充血心肌血流量低于第2组(2.0 vs 2.60 mL/min/g,P=.018)。
  • 第1组冠状动脉血流储备均数和中位数均较第2组显著降低(2.07±0.74 vs 2.63±0.48,P=.025)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk stratification and early detection of cardiac allograft vasculopathy (CAV) is essential in orthotopic heart transplantation (OHT) patients. This study assesses the changes in myocardial blood flow (MBF) noninvasively in OHT patients using quantitative cardiac PET with regadenoson. METHODS: Twelve patients (Group 1) (8 males, 4 females, mean age 55 ± 7 years) with no history of post OHT myocardial ischemia were enrolled 5.4 ± 2.0 years after OHT. Fifteen patients (Group 2) (9 males, 6 females, mean age 71 ± 9 years) with intermediate pretest probability but not documented evidence for coronary artery disease (CAD) were also included to serve as control. Global and regional MBFs were assessed using dynamic 13N-NH3 PET at rest and during regadenoson-induced hyperemia. The coronary flow reserve (CFR) was also calculated as the ratio of hyperemic to resting MBF. RESULTS: Mean regadenoson-induced rate-pressure products were similar in both groups, while there was an increase in resting rate-pressure product in Group 1 patients. Both mean and median values of resting MBF were higher in Group 1 than Group 2 patients (1.33 ± 0.31 and 1.01 ± 0.21 mL/min/g for Groups 1 and 2, respectively, P < .001), while mean hyperemic MBF values were similar in both Groups (2.68 ± 0.84 and 2.64 ± 0.94 mL/min/g, P = NS) but median hyperemic MBF values were lower in Group 1 than Group 2 patients (2.0 vs. 2.60 mL/min/g, P = .018). Both mean and median CFR values demonstrated a significant reduction for Group 1 compared to Group 2 patients (2.07 ± 0.74 vs 2.63 ± 0.48, P = .025). CONCLUSIONS: This study suggests that the MBF in OHT patients may be abnormal at resting state with diminished CFR. This hints that the epicardial and microvascular coronary subsystem may be exacerbated after OHT leading to the gradual progression of CAV.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Pampaloni MH, Shrestha UM, Sciammarella M, et al. Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients. J Nucl Cardiol. 2017. PMID: 28138813. doi:10.1007/s12350-016-0761-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。